Figure 3.
EpoRm transduces stronger proliferation and survival signals than EpoR. (A) Flow cytometric contour plots illustrate phosphorylation of STAT5 in T cells transduced with EpoR, EpoRm, or GFP only after stimulation with Epo (10 IU/mL) for 15 minutes. (B) Percentage of GFP+ cells expressing pSTAT5 in T cells transduced with EpoR, EpoRm, or GFP only after stimulation with 10 IU/mL Epo or treated with 10 µM ruxolitinib before Epo stimulation. Each symbol represents results of 1 experiment. ****P < .0001; **P < .01. (C) Flow cytometry dot-plots illustrate cell cycle analysis of T lymphocytes transduced with EpoR, EpoRm, or GFP only, unstimulated (top row) or stimulated with 10 IU/mL Epo (bottom row) after 3 days of culture in cytokine-free medium. DNA content, detected by FxCycle staining, is shown on the x-axes; DNA synthesis, shown by 5-ethynyl-2′-deoxyuridine (Edu) incorporation, is shown on the y-axes. Edu+ cells are shown in red, with their percentage. (D) Survival of T lymphocytes transduced with EpoR, EpoRm, or GFP-only cultured in absence of exogenous cytokines (no Epo) or in presence of Epo (10 IU/mL) for 3 weeks. Symbols indicate mean (± SD) percentage of cell recovery relative to the number of input cells in triplicate measurements. ****P < .0001; **P < .01; *P = .01. (E) Percentage of T-cell recovery relative to input cells after 6 to 8 days’ culture with or without 100 IU/mL IL-2 and/or 10 IU/mL Epo. Each symbol indicates measurements with T cells of 1 of 4 donors (mean of 3 measurements for 3 donors, and 1 measurement for 1 donor). *P = .02. (F) Survival of T lymphocytes transduced with EpoR, EpoRm, or GFP only cultured with 100 IU/mL IL-2 in the absence or presence of Epo (10 IU/mL). Percentage of T-cell recovery relative to input cells at the indicated days is shown.

EpoRm transduces stronger proliferation and survival signals than EpoR. (A) Flow cytometric contour plots illustrate phosphorylation of STAT5 in T cells transduced with EpoR, EpoRm, or GFP only after stimulation with Epo (10 IU/mL) for 15 minutes. (B) Percentage of GFP+ cells expressing pSTAT5 in T cells transduced with EpoR, EpoRm, or GFP only after stimulation with 10 IU/mL Epo or treated with 10 µM ruxolitinib before Epo stimulation. Each symbol represents results of 1 experiment. ****P < .0001; **P < .01. (C) Flow cytometry dot-plots illustrate cell cycle analysis of T lymphocytes transduced with EpoR, EpoRm, or GFP only, unstimulated (top row) or stimulated with 10 IU/mL Epo (bottom row) after 3 days of culture in cytokine-free medium. DNA content, detected by FxCycle staining, is shown on the x-axes; DNA synthesis, shown by 5-ethynyl-2′-deoxyuridine (Edu) incorporation, is shown on the y-axes. Edu+ cells are shown in red, with their percentage. (D) Survival of T lymphocytes transduced with EpoR, EpoRm, or GFP-only cultured in absence of exogenous cytokines (no Epo) or in presence of Epo (10 IU/mL) for 3 weeks. Symbols indicate mean (± SD) percentage of cell recovery relative to the number of input cells in triplicate measurements. ****P < .0001; **P < .01; *P = .01. (E) Percentage of T-cell recovery relative to input cells after 6 to 8 days’ culture with or without 100 IU/mL IL-2 and/or 10 IU/mL Epo. Each symbol indicates measurements with T cells of 1 of 4 donors (mean of 3 measurements for 3 donors, and 1 measurement for 1 donor). *P = .02. (F) Survival of T lymphocytes transduced with EpoR, EpoRm, or GFP only cultured with 100 IU/mL IL-2 in the absence or presence of Epo (10 IU/mL). Percentage of T-cell recovery relative to input cells at the indicated days is shown.

Close Modal

or Create an Account

Close Modal
Close Modal